Product Reports Resources Pricing Login Book a demo
Martine Clozel
Person deep dive

Martine Clozel

Martine Clozel is a French-Swiss scientist who co-founded Actelion in 1997 and led its research, and Johnson & Johnson bought it for about $30B in 2017. She then co-founded Idorsia, spun out of Actelion and listed in Switzerland in 2017, where she is chief scientific officer.

Track record

Companies Martine Clozel founded or backed, with what became of them.

Idorsia

FirmIdorsia
Founded2017
Based inAllschwil, Switzerland
FocusDrug discovery and development, spun out of Actelion

Career

  1. Early careerTrained as a doctor at the University of Nancy, specialising in paediatrics and neonatal intensive care, then in physiology and pharmacology at McGill and UCSF.
  2. Before 1997Worked as an assistant professor of neonatology, then led drug discovery projects at F. Hoffmann-La Roche.
  3. 1997Co-founded Actelion in December with Jean-Paul Clozel, Walter Fischli, André J. Müller and Thomas Widmann, all from Roche.
  4. 2000Actelion listed on the SIX Swiss Exchange.
  5. 2009Became Actelion's chief scientific officer after 12 years as head of drug discovery, pharmacology and preclinical development.
  6. 2017Johnson & Johnson agreed in January to buy Actelion for about $30B; its early research was spun out as Idorsia, which listed in June.
  7. 2022Idorsia's insomnia drug daridorexant (Quviviq) won EU approval in May; she received the Prix Suisse.
  8. 2023Idorsia cut up to 500 of about 1,200 jobs and sold its Japan and South Korea business to Sosei Heptares for CHF 400M.

Sources: Idorsia: Our people · Wikipedia: Martine Clozel · Wikipedia: Actelion · Wikipedia: Idorsia · cash.ch: The woman behind the success of Idorsia and Actelion.

Companies founded

← All people